The Effect of Phloroglucinol in Patients With Diarrhea-predominant Irritable Bowel Syndrome: A Randomized, Double-blind, Placebo-controlled Trial

BACKGROUND/AIMS: We aim to evaluate the efficacy and safety of phloroglucinol in patients with diarrhea-predominant irritable bowel syndrome (IBS-D). METHODS: Seventy-two patients with IBS-D who met Rome III criteria were 1:1 randomized in a parallel, double-blind design to receive phloroglucinol or...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Seung Yong, Cha, Bong Ki, Kim, Won-Seok, Park, Jae Yong, Kim, Jeong Wook, Choi, Chang Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Neurogastroenterology and Motility 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955199/
https://www.ncbi.nlm.nih.gov/pubmed/31917916
http://dx.doi.org/10.5056/jnm19160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955199/
https://www.ncbi.nlm.nih.gov/pubmed/31917916
http://dx.doi.org/10.5056/jnm19160

Ejemplares similares